Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
|
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
    Jialei Wang
    Jianhua Chang
    Hui Yu
    Xianghua Wu
    Huijie Wang
    Wenhua Li
    Dongmei Ji
    Wei Peng
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 905 - 911
  • [32] A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
    Wang, Jialei
    Chang, Jianhua
    Yu, Hui
    Wu, Xianghua
    Wang, Huijie
    Li, Wenhua
    Ji, Dongmei
    Peng, Wei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 905 - 911
  • [33] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [34] COMBINATION CHEMOTHERAPY WITH CISPLATIN, BLEOMYCIN AND METHOTREXATE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    JAHNKE, V
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1980, 227 (3-4): : 566 - 567
  • [35] Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer
    Jeong, Hye Cheol
    Lee, Sang Yeub
    Kim, Jung Ha
    Ha, Eun Sil
    Jung, Jin Yong
    Lee, Kyung Ju
    Lee, Seung Hyeun
    Kim, Se Joong
    Lee, Eun Joo
    Hur, Gyu Young
    Lee, Sung Yong
    Kim, Je Hyeong
    Shin, Chol
    Shim, Jae Jeong
    In, Kwang Ho
    Kang, Kyung Ho
    Yoo, Se Hwa
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2006, 60 (01) : 57 - 64
  • [36] Retrospective study of continued immunotherapy in patients with advanced esophageal squamous cell carcinoma after progression on first-line immunotherapy combination chemotherapy.
    Yu, Weiyong
    Wan, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Discontinuation of first-line chemotherapy (CT) after 6 weeks of CT in patients (pts) with metastatic squamous-cell esophageal cancer (MSEC): A randomized phase II trial
    Adenis, Antoine
    Bennouna, Jaafar
    Etienne, Pierre-Luc
    Bogart, Emilie
    Francois, Eric
    Galais, Marie-Pierre
    Ben Abdelghani, Meher
    Kotecki, Nuria
    Michel, Pierre
    Metges, Jean-Philippe
    Dahan, Laetitia
    Piessen, Guillaume
    Conroy, Thierry
    Ghiringhelli, Francois
    Bedenne, Laurent
    El Hajbi, Farid
    Samalin, Emmanuelle
    Delaine, Stephanie Clisant
    Penel, Nicolas
    Mariette, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC
    Spigel, David
    Luft, Alexander
    Vynnychenko, Ihor
    Fadeeva, Natalia
    Mark, Zsuzsanna
    Ponce, Santiago
    Matrosova, Marina
    Goldschmidt, Jerome
    Szima, Barna
    Saleh, Mansoor
    Lackner, Mark
    Gendreau, Steve
    Bassett, Katia
    Spoerke, Jill
    Koeppen, Hartmut
    Gilbert, Houston
    Jin, Huan
    Shankar, Geetha
    Lin, Wei
    Denis, Fabrice
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S375 - S375
  • [39] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [40] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345